R-Pharm invests US$200 million in pharmaceutical plant in Alatau

Investment & companiesGrowing1 Source

Published 9 Nov 2026 · last updated 9 Nov 2026 · 2 Nov 2025

Russian R-Pharm Group plans to build a biopharmaceutical hub in Alatau in partnership with Khan Tengri Biopharma. The joint venture is to be implemented within three years, following the allocation of a land plot. Production will serve both the domestic Kazakh market and exports.

District: Growing (derived from the type of project)

Key facts

• Investment volume: US$200 million
• Partners: R-Pharm Group and Khan Tengri Biopharma
• Implementation: Within three years
• Location: Alatau, land plot already allocated
• Market: Kazakhstan and export

All sources (1)

1. Russia’s R-Pharm To Invest US$200 Million Into Kazakh Pharmaceutical Factoryrussia's pivot to asia · 2 Nov 2025 · EN